185 related articles for article (PubMed ID: 12380962)
1. The effects of anemia and anemia treatment on the quality of life of people with cancer.
Cella D
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):125-32. PubMed ID: 12380962
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
4. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
5. Effects of cancer-related anemia on clinical and quality-of-life outcomes.
Gillespie TW
Clin J Oncol Nurs; 2002; 6(4):206-11. PubMed ID: 12087616
[TBL] [Abstract][Full Text] [Related]
6. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
Quirt I; Micucci S; Moran LA; Pater J; Browman G
Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
[TBL] [Abstract][Full Text] [Related]
8. Cancer-related anemia: clinical review and management update.
Hurter B; Bush NJ
Clin J Oncol Nurs; 2007 Jun; 11(3):349-59. PubMed ID: 17623620
[TBL] [Abstract][Full Text] [Related]
9. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
10. Cancer-related anemia and recombinant human erythropoietin--an updated overview.
Bohlius J; Weingart O; Trelle S; Engert A
Nat Clin Pract Oncol; 2006 Mar; 3(3):152-64. PubMed ID: 16520805
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietic agents in the management of cancer patients. Part 1: Anemia, quality of life, and possible effects on survival.
Smith RE
J Support Oncol; 2003; 1(4):249-56, 258-9; discussion 257-8. PubMed ID: 15334867
[TBL] [Abstract][Full Text] [Related]
12. Anemia in cancer patients: significance, epidemiology, and current therapy.
Tchekmedyian NS
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):17-24. PubMed ID: 12380951
[TBL] [Abstract][Full Text] [Related]
13. Practitioners' practical model for managing cancer-related anemia.
Smith RE; Tchekmedyian S
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):55-63. PubMed ID: 12380955
[TBL] [Abstract][Full Text] [Related]
14. Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument.
Mäenpää J; Puistola U; Riska H; Sintonen H; Saarni O; Juvonen E; Kellokumpu-Lehtinen PL
Anticancer Res; 2014 May; 34(5):2325-9. PubMed ID: 24778039
[TBL] [Abstract][Full Text] [Related]
15. EPO in cancer anemia: benefits and potential risks.
Milano M; Schneider M
Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
17. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.
Glaspy J
Semin Hematol; 1997 Jul; 34(3 Suppl 2):20-6. PubMed ID: 9253780
[TBL] [Abstract][Full Text] [Related]
18. Anemia impact and management: focus on patient needs and the use of erythropoietic agents.
Bokemeyer C; Foubert J
Semin Oncol; 2004 Jun; 31(3 Suppl 8):4-11. PubMed ID: 15181603
[TBL] [Abstract][Full Text] [Related]
19. Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.
Smith RE; Jaiyesimi IA; Meza LA; Tchekmedyian NS; Chan D; Griffith H; Brosman S; Bukowski R; Murdoch M; Rarick M; Saven A; Colowick AB; Fleishman A; Gayko U; Glaspy J
Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):24-30. PubMed ID: 11308271
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
